SHANGHAI (Reuters) - Pfizer Inc will invest $350 million to build a biotech center in China, the latest in a series of moves by pharma industry giants to set up shop in the world's no. 2 drugs market with the aim of securing faster approvals for their products.

BING NEWS:
  • 3 Biotech Stocks to Buy on the Dip: April 2024
    If you follow Warren Buffett’s advice of being greedy when others are fearful, then it probably makes sense to consider biotech stocks to buy on the dip. Primarily, the thesis centers on the ...
    04/25/2024 - 11:00 pm | View Link
  • Improved US biotech funding to aid FY25 growth, expects Jonathan Hunt, MD & CEO, Syngene International
    Syngene International reported 6% year-on-year rise in net profit during Q4 while revenues declined 8%. As funding challenges from US biotech leading to decreased demand for R&D services, has impacted ...
    04/24/2024 - 9:18 pm | View Link
  • Chips 2.0 for biomanufacturing, and other big ideas from MassBio conference
    Speakers at MassBio’s conference focused on how despite industry headwinds and global challenges, Massachusetts has remained a global biotech leader — and highlighted the ways Massachusetts still ...
    04/24/2024 - 10:24 am | View Link
  • Canaan hires Pfizer executive, reels in $100M for biotech investing
    The firm has brought in as venture partner Uwe Schoenbeck, who most recently was the top scientist for Pfizer’s emerging science and innovation unit.
    04/17/2024 - 6:19 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News